Edit Symbol List
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
ETFs with UTHR as a Top 10 Holding*
|Weighting||ETF Name (Symbol)||100-Day Price Change (%)|
|2.47%||Guggenheim S&P Midcap 400 Pure Growth ETF (RFG)||-6.42 (-4.83%)|
|0.79%||PowerShares Russell 2000 Pure Growth Portfolio (PXSG)||-1.57 (-6.09%)|
|0.26%||Schwab U.S. Small-Cap ETF (SCHA)||-5.69 (-9.81%)|
Company Description (as filed with the SEC)
United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of innovative products to address the unmet medical needs of patients with chronic and life-threatening conditions. Our key therapeutic products and product candidates include: º * º Prostacyclin Analogues. Prostacyclin analogues are stable synthetic forms of prostacyclin, an important molecule produced by the body that has powerful effects on blood vessel health and function. Our lead product is Remodulin® (treprostinil) Injection (Remodulin), which is administered subcutaneously (under the skin) or intravenously (in the vein) for the treatment of pulmonary arterial hypertension (PAH) to diminish symptoms associated with exercise. ... More ...
Where does UTHR fit in the risk graph?
|Annual EPS Est:||$7.4|
|Quarterly EPS Est:||2.41|